Merck & Co., Inc. — Director's Dealing 2017

Nov 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2017-11-09

Reporting Person: Chattopadhyay Sanat (Exe V-P & Pres. MMD)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-09	Phantom Stock	$	I	13099.5210	Acquired		Common Stock (13099.5210)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	43295.7300	Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each share of phantom stock is the economic equivalent of one share of Merck common stock and was granted under the Merck & Co., Inc. Deferral Program (the "Program"). The Program includes the right of redesignation to other investment measures within the Program.